These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Systemic lupus erythematosus associated with antiribosomal P protein antibody. Takehara K; Nojima Y; Kikuchi K; Igarashi A; Soma Y; Tsuchida T; Ishibashi Y Arch Dermatol; 1990 Sep; 126(9):1184-6. PubMed ID: 2204307 [TBL] [Abstract][Full Text] [Related]
23. Antineutrophil cytoplasmic autoantibodies. Roberts DE Clin Lab Med; 1992 Mar; 12(1):85-98. PubMed ID: 1314157 [TBL] [Abstract][Full Text] [Related]
24. Prevalence of cytoplasmic antibodies in systemic lupus erythematosus. Wu YC; Tung CC; Deng JS; Lü YC Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1976 Dec; 9(3-4):45-8. PubMed ID: 1037534 [TBL] [Abstract][Full Text] [Related]
25. Antibodies in systemic lupus antineutrophil cytoplasmic erythematosus: prevalence, disease activity correlations and organ system associations. Fauzi AR; Kong NC; Chua MK; Jeyabalan V; Idris MN; Azizah R Med J Malaysia; 2004 Aug; 59(3):372-7. PubMed ID: 15727383 [TBL] [Abstract][Full Text] [Related]
26. [Studies on autoantibodies in systemic lupus erythematosus with peroxidase-labeled antibody technic. Ultrastructural localization of the antigens and a test for antinuclear and anticytoplasmic factors]. Machida M Nihon Naika Gakkai Zasshi; 1971 May; 60(5):408-19. PubMed ID: 4939865 [No Abstract] [Full Text] [Related]
27. [Clinico-biological classification of systemic lupus]. Meyer O Ann Med Interne (Paris); 1990; 141(3):229-33. PubMed ID: 2369011 [TBL] [Abstract][Full Text] [Related]
30. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review. Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672 [TBL] [Abstract][Full Text] [Related]
31. Diffuse alveolar hemorrhage in systemic lupus erythematosus: risk factors and clinical outcome: results from affiliated hospitals of Catholic University of Korea. Kwok SK; Moon SJ; Ju JH; Park KS; Kim WU; Cho CS; Kim HY; Park SH Lupus; 2011 Jan; 20(1):102-7. PubMed ID: 20956464 [TBL] [Abstract][Full Text] [Related]
33. The clinical significance of autoantibodies to a soluble cytoplasmic antigen in systemic lupus erythematosus and other connective tissue diseases. Maddison P; Mogavero H; Provost TT; Reichlin M J Rheumatol; 1979; 6(2):189-95. PubMed ID: 88520 [TBL] [Abstract][Full Text] [Related]
35. Pathogenetic role of anti-vascular endothelial cell antibodies in systemic lupus erythematosus. Zhou SF; Wang XM; Zhong HP; Li A; Wang MX; Wang SL; Zhang L; Du XH Chin Med J (Engl); 1989 Jul; 102(7):505-9. PubMed ID: 2517066 [TBL] [Abstract][Full Text] [Related]
36. Clinical significance of combined antinuclear and anticytoplasmic antibodies detected by immunofluorescence. Lee TK; Rothberger H Chin Med J (Engl); 1989 Dec; 102(12):911-5. PubMed ID: 2517735 [TBL] [Abstract][Full Text] [Related]
37. [A case of diffuse alveolar hemorrhage accompanied by mesangial proliferative glomerulonephritis with positive perinuclear anti-neutrophil cytoplasmic antibody]. Mouri M; Nambu Y; Miyazaki H; Yamanouchi K; Toga H; Ohya N Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Aug; 32(8):785-90. PubMed ID: 7807759 [TBL] [Abstract][Full Text] [Related]